Oak Longevity vs Wellorithm: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Oak Longevity beats Wellorithm overall, scoring 7.5/10 vs 7.4/10. Oak Longevity is more affordable at $133/mo vs $147/mo. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound. Choose Wellorithm for cash-pay patients who want compounded semaglutide or tirzepa.
A side-by-side look at Oak Longevity and Wellorithm to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Oak Longevity
#25 of 53Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing, patients pay each month manually rather than auto-renew.
Visit Oak LongevityWellorithm
#29 of 53Telehealth platform for compounded semaglutide and tirzepatide that uniquely offers BOTH injectable and oral dissolving tablet formats, paired with a 10% weight-loss guarantee that refunds up to four months of program fees if the patient does not lose at least 10% of baseline weight after 16 weeks of medication adherence (terms apply). 28-day recurring billing, non-refundable per-cycle, with a documented address listed in Berlin, Germany.
Visit Wellorithm| Feature | Oak Longevity | Wellorithm |
|---|---|---|
| Our Score | 7.5/10 | 7.4/10 |
| Starting Price | $133/mo | $147/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin) | Cash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support |
| Watch out for | Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct | Founding year, corporate ownership, and named prescribers are NOT publicly disclosed, and the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients; if disclosed leadership matters to you, weigh this first |
| Ranking | #25 | #29 |
| Get started | Visit Oak Longevity | Visit Wellorithm |
Pros & Cons Compared
Oak Longevity
Pros
- +$133/mo for compounded semaglutide is among the cheapest entries on the market, Sesame Care ($99) is lower, but Oak undercuts most mid-tier platforms
- +No-subscription model, patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
- +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
- +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
- +Money-back guarantee if not approved by physician, useful safety net for borderline-eligibility patients
- +Free shipping and free health coaching included in every program
Cons
- −Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct
- −No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
- −The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan
- −The longevity add-ons (NAD+, Sermorelin, Tesamorelin) have limited clinical evidence for weight loss specifically, if weight loss is the goal, the GLP-1 alone does the work and the stack is optional
- −Newer brand without disclosed company history, founding date, or executive team on landing pages
- −Three-month plans are billed upfront, start on the 1-month plan if you're testing the platform, then bundle once it fits
Wellorithm
Pros
- +Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats, semaglutide and tirzepatide each in two formats, broader format menu than most compounded-only platforms
- +10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
- +Competitive entry pricing, $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market
- +2-minute qualification quiz, virtual consultation, 24/7 support availability claimed
- +23,000+ reviews and 4.9-star rating reported (volume is unusually high for this market segment, verify on independent third-party sources before relying on it)
- +Spring promotion advertised at $147 with free shipping included
Cons
- −Founding year, corporate ownership, and named prescribers are NOT publicly disclosed, and the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients; if disclosed leadership matters to you, weigh this first
- −49 states only, service is unavailable in Louisiana and outside the United States
- −Billing runs on a 28-day recurring cycle and payments are non-refundable once processed, with no proration for partial months; cancel before your next cycle processes to avoid paying for an unused month
- −Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo; FDA does not review compounded medications for safety, effectiveness, or manufacturing quality
- −The weight-loss guarantee has strict eligibility terms: verified weight documentation (doctor attestation or video evidence), prior medication history disclosure, consistent dosing adherence, and refund processed within 30 days of approval, with only fees actually paid refundable and baseline payments non-refundable; document your starting weight from day one if you plan to rely on it
- −Two different affiliate landing pages (campaign-7 and qoroxapi/lead.php direct route) run different funnel structures, so the post-click experience can vary
Our Verdict
Oak Longevity edges out Wellorithm with a score of 7.5/10 vs 7.4/10. If budget is your priority, Oak Longevity starts at $133/mo compared to Wellorithm's $147/mo. Oak Longevity offers both brand-name and compounded medications, giving you more flexibility. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin). Choose Wellorithm if you want: cash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support.
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither Oak Longevity nor Wellorithm feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing Oak Longevity or Wellorithm tend to look at next.
- Oak Longevity vs Found$129/mo
- Oak Longevity vs GobyMeds$169/mo
- Oak Longevity vs bmiMD$119/mo
- Wellorithm vs TrimRx$149/mo
- Wellorithm vs Strut Health$149/mo
- Wellorithm vs Maximus$150/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.